Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
6.42
-0.14 (-2.21%)
Oct 10, 2025, 1:14 PM EDT - Market open

Champions Oncology Revenue

Champions Oncology had revenue of $14.00M in the quarter ending July 31, 2025, a decrease of -0.47%. This brings the company's revenue in the last twelve months to $56.88M, up 10.11% year-over-year. In the fiscal year ending April 30, 2025, Champions Oncology had annual revenue of $56.94M with 13.54% growth.

Revenue (ttm)
$56.88M
Revenue Growth
+10.11%
P/S Ratio
1.58
Revenue / Employee
$267,033
Employees
213
Market Cap
88.45M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Apr 30, 202556.94M6.79M13.54%
Apr 30, 202450.16M-3.72M-6.90%
Apr 30, 202353.87M4.76M9.69%
Apr 30, 202249.11M8.07M19.66%
Apr 30, 202141.04M8.92M27.76%
Apr 30, 202032.12M5.06M18.68%
Apr 30, 201927.07M6.83M33.72%
Apr 30, 201820.24M4.83M31.34%
Apr 30, 201715.41M4.23M37.82%
Apr 30, 201611.18M2.32M26.16%
Apr 30, 20158.86M-2.69M-23.26%
Apr 30, 201411.55M3.23M38.77%
Apr 30, 20138.32M1.17M16.42%
Apr 30, 20127.15M267.00K3.88%
Apr 30, 20116.88M1.99M40.65%
Apr 30, 20104.89M1.18M31.89%
Apr 30, 20093.71M2.31M165.00%
Apr 30, 20081.40M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings